207 related articles for article (PubMed ID: 35693768)
1. Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination.
Sprow G; Afarideh M; Dan J; Feng R; Keyes E; Grinnell M; Concha J; Werth VP
Front Immunol; 2022; 13():899526. PubMed ID: 35693768
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK
J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018
[TBL] [Abstract][Full Text] [Related]
3. The relationship between COVID-19 vaccination status in pregnancy and birthweight.
Gaur P; Darwin KC; Kohn JR; Uribe KA; Shippey E; Eke AC
Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101057. PubMed ID: 37330010
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus.
Giannopoulou N; Gupta L; Andreoli L; Lini D; ; Nikiphorou E; Aggarwal R; Agarwal V; Parodis I
Autoimmun Rev; 2023 Apr; 22(4):103292. PubMed ID: 36740090
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
Hinterseher J; Hertl M; Didona D
J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
[TBL] [Abstract][Full Text] [Related]
7. Association between COVID-19 vaccines and development of chronic morbidities: a cross-sectional study in the Jordanian population.
Al-Hawamdeh MI; Abu-Huwaij R; Astiti TA; Al-Debe'e AK; Abazeed OJ; Raees MA
Curr Med Res Opin; 2024 Mar; 40(3):537-543. PubMed ID: 38193825
[TBL] [Abstract][Full Text] [Related]
8. Risk of autoimmune skin and connective tissue disorders after mRNA-based COVID-19 vaccination.
Ju HJ; Lee JY; Han JH; Lee JH; Bae JM; Lee S
J Am Acad Dermatol; 2023 Oct; 89(4):685-693. PubMed ID: 37187424
[TBL] [Abstract][Full Text] [Related]
9. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
[TBL] [Abstract][Full Text] [Related]
10. Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination.
Šinkovec Savšek T; Zajc Avramovič M; Avčin T; Korva M; Avšič Županc T; Toplak N
Pediatr Rheumatol Online J; 2023 May; 21(1):46. PubMed ID: 37208721
[TBL] [Abstract][Full Text] [Related]
11. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.
Formeister EJ; Wu MJ; Chari DA; Meek R; Rauch SD; Remenschneider AK; Quesnel AM; de Venecia R; Lee DJ; Chien W; Stewart CM; Galaiya D; Kozin ED; Sun DQ
JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):307-315. PubMed ID: 35201274
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
Gil-Vila A; Ravichandran N; Selva-O'Callaghan A; Sen P; Nune A; Gaur PS; Gonzalez RA; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Muscle Nerve; 2022 Oct; 66(4):426-437. PubMed ID: 35869701
[TBL] [Abstract][Full Text] [Related]
14. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
15. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
[TBL] [Abstract][Full Text] [Related]
16. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
[TBL] [Abstract][Full Text] [Related]
18. Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort.
Apaydin H; Erden A; Güven SC; Armağan B; Konak HE; Polat B; Afşin Y; Kaygisiz M; Omma A; Kucuksahin O
Int J Rheum Dis; 2022 Sep; 25(9):1068-1077. PubMed ID: 35851753
[TBL] [Abstract][Full Text] [Related]
19. Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report.
Aouintia I; Daly W; Lakhoua G; Kaabi W; Charfi O; Debbeche S; Kastalli S; Zaiem A; El Aidli S
Curr Drug Saf; 2024; 19(2):306-308. PubMed ID: 37317919
[TBL] [Abstract][Full Text] [Related]
20. Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.
Mohanasundaram K; Santhanam S; Natarajan R; Murugesan H; Nambi T; Chilikuri B; Nallasivan S
Int J Rheum Dis; 2022 Sep; 25(9):1046-1052. PubMed ID: 35773944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
